Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 12 June 2025
      EFPIA response to the European Commission call for evidence on the EU Biotech Act
 
 
Read our submission here.
 

EFPIA strongly support the ambition to foster a world-class innovation environment for biotechnologies. To make the EU more competitive, we urge coordinated and urgent action across several areas.

  • Reinforce internationally competitive IP protection rules. 
  • Simplify, speed up and harmonise the EU framework for clinical trials. 
  • Establish a center of excellence for manufacturing innovation. 
  • Modernise the EU regulatory ecosystem.  
  • Unlock broader use of private investments. 
  • Boost digitalisation for biotech development. 
Read more →
 
 
      Blogs
 
  12 June 2025 From Principle to Practice: Paving the Future Beyond Animal Testing

Helping to shape a roadmap to phase out animal testing for chemical safety assessments

Read more →
 
 
 
      Videos
 
 
 
The importance of clinical trials

Ensuring patients have access to the latest advances in medical innovation.

 
 
EFPIA's highlights at the Euractiv Health Policy Conference

With Roberta Savli, EFPIA Executive Director of Public Affair.

 
 
 
 
      Events
 
 
23 JUN 2025
  IHI Call Days - call 11 Virtual event

The IHI Call Days for IHI call 11 will take place from 23 to 30 June 2025 online and will include sessions on the individual...

Learn more →
 
 
 
24 JUN 2025
  EUDF: Increasing productivity, competitiveness and resilience by tackling the interplay... European Parliament, Brussels

On 24 June, EUDF is hosting a policy-focused event in collaboration with MEP Ignazio Marino, to explore the vital connection...

Learn more →
 
 
      Recent publications
Almost 100 new medicine approvals tracked; new data gives clearest picture yet of delays for... 14 May 2025 (News & Events)
EFPIA also publishes first report aimed specifically as a catalyst for action to tackle inequalities faced by smaller...
Read more →
New data shows no shift in access to medicines for millions of Europeans 07 May 2025 (News & Events)
EFPIA says perennial state of medicines inequality requires rapid action from multiple partners to address numerous...
Read more →
 
      What we are reading
EMA Annual Report 2024 10 June 2025  (EMA) Read more →
Delivering regulatory impact from consortium-based projects 09 June 2025  (Nature) Read more →
Going green: meet the projects boosting the environmental performance of the health sector 05 June 2025  (IHI) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe